To include your compound in the COVID-19 Resource Center, submit it here.

InflaRx prices $100M IPO

InflaRx N.V. (NASDAQ:IFRX) raised $100 million on Wednesday through the sale of

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE